CompletedNot Applicable

MI-based PrEP Intervention

United States86 participantsStarted 2019-01-10

Plain-language summary

Gay, bisexual and other men who have sex with men (MSM) are the group at highest risk of HIV infection in the United States. Pre-exposure prophylaxis (PrEP) has demonstrated high efficacy in preventing HIV infection among MSM. However, uptake in clinical settings has been slow for several reasons, including low awareness and education, low perceived HIV risk, concern for side-effects, and stigma associated with taking the medication. The purpose of the proposed study is to develop and evaluate a brief motivational interviewing (MI) intervention to promote PrEP uptake among MSM during the course of routine HIV screening at a public sexually transmitted disease (STD) clinic.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 years of age or older
✓. Assigned male at birth and currently identify as male
✓. Score at least 10 on the HIV Incident Risk Index for MSM
✓. HIV-negative based on results of antibody test
✓. English- or Spanish-speaking
✓. Have access to a working phone
✓. Have not taken PrEP

Exclusion criteria

✕. Have previously taken PrEP
✕. Symptoms of acute HIV infection at baseline
✕. HIV positive
✕. A clinical contraindication to PrEP (e.g., renal dysfunction)
✕. Non-English or non-Spanish speaking

What they're measuring

PrEP uptake

Timeframe: Three months

Trial details

NCT IDNCT03313765

SponsorThe Miriam Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-04-30

View on ClinicalTrials.gov More PrEP Uptake trials